News
New York City public hospitals to make abortion care available via telehealth
From this week, women in New York City will be able to access safe, legal abortion care from home

New York City public hospitals will now offer abortion via telehealth, making NYC Health + Hospitals the first public health system in the US to do so.
Starting this week, patients in New York City seeking abortion care will be able to schedule a Virtual ExpressCare appointment to speak with a New York state-licensed health care professional by video or phone, on-demand, for an assessment and counselling.
If clinically appropriate and prescribed, patients will be able to receive a medication abortion kit at their New York City address within a few days.
This service will be available seven days a week and will provide patients with access to safe, legal abortion care.
NYC Health + Hospitals already offers access to medication and procedural abortion services at their hospital-based clinics. The launch is hoped to further expand New Yorkers’ access to abortion care.
“Here in New York City, we will not allow the far right to continue its crusade to strip women of their reproductive rights,” said New York City mayor, Eric Adams.
“Last year, an activist Supreme Court undermined almost 50 years of settled law by overturning Roe v Wade, but New Yorkers know that access to safe, legal abortion care is the cornerstone of public health, and we will not stand idly by as these attacks on women continue.
“Today, I am proud to announce another first for any city government: Access to abortion care will now be available through telehealth visits at NYC Health + Hospitals sites from the comfort of one’s home.”
He added: “In New York City, we will never stop fighting for a woman’s right to choose the care that is right for them, and we will never stop working to make abortion care more accessible to all New Yorkers.
“Telehealth abortion care allows the people in our lives to make the choices they need privately and safely, so that they can decide what is best for them and their futures. This is about protecting the ability for women to control their own bodies, their choices, and their freedoms.”
Deputy mayor for health and human services, Anne Williams-Isom, said: “Since the Dobbs Supreme Court decision in June of 2022, the city has acted to strengthen access to reproductive care through both the New York City Department of Health and Mental Hygiene, as well as our city’s public hospital system for any person who needs it.
“Adding Virtual ExpressCare to that suite of options for patients at NYC Health + Hospitals is an important next step in making reproductive health care conversations easy, accessible, and convenient for every person. Thank you to the NYC Health + Hospitals team that makes this work possible.”
Marisa Nádas, MD, MPH, reproductive health clinical lead at NYC Health + Hospitals and associate medical director at Virtual ExpressCare, added: “As our country faces a devastating loss of reproductive rights, New Yorkers should know that they can access safe and legal abortion care.
“By offering access to assessment and counselling for abortion care – as well as the possibility of a remote medication abortion – through Virtual ExpressCare, we are navigating around barriers people face in coming for in-person appointments and further opening up access.”
Wendy Stark, president and CEO at Planned Parenthood of Greater New York, described the initiative as a historic win for abortion access in New York City.
“I applaud NYC Health + Hospitals for taking this important stride with telehealth abortion services that allow New Yorkers to access critical abortion care from the comfort of their own homes, without worrying about barriers to care like transportation and significant time off from work,” she said.
“When we make abortion care more accessible, we empower individuals to make the best decisions for themselves, their families, and their futures.”
New York state senator, Liz Krueger, said: “Ensuring that all people have the right to abortion care is not just about legal protections, it’s also about making sure that care is really accessible on the ground.
“Making medication abortion available through telehealth is a critical option for people who, for whatever reason, may not be able to easily get to a doctor’s office or clinic. And it reduces the need for more costly and involved procedures.
“I thank Mayor Adams and NYC Health + Hospitals for making this important option available”
Brad Hoylman-Sigal, New York state senator, added: “Today, New York continues to lead the nation in protecting bodily autonomy.
“While other states roll back reproductive rights and rewind the clock of progress, New York is launching telehealth abortion access: the most accessible and modern form of reproductive health care in the country.
“I applaud mayor Adams and NYC Health + Hospitals for breaking down barriers to this critical form of health care and ensuring New York will always be a safe haven for women across the United States to exercise their right to choose.”
The new telehealth abortion service by NYC Health + Hospitals is based in and for New York City. Patients must attest to being in New York City at the time of the call and must attest that they will be in New York City when they take the medication.
Medication abortion prescribed during a telehealth appointment is available to clinically eligible patients who are up to 10 weeks into their pregnancy. If a patient chooses to receive abortion medication by mail, the address must be in New York City.
Adolescent health
Newly-launched Female Health Hub will support grassroots football players

A new Female Health Hub launched by the English FA will support women and girls in grassroots football in England with trusted advice on health issues affecting play.
The hub brings together expert-backed guidance, practical tools and player insights in one place, giving women and girls practical advice and reassurance on female health in football.
It has four core aims: to help women and girls better understand their bodies and how female health affects performance and participation, to educate players on key health topics and when to seek further advice or support, to provide practical strategies to help navigate common female health challenges, and to help break down taboos and normalise conversations around female health in football.
Users of the hub will also be able to hear directly from members of the England women’s national team, who share their own experiences of navigating female health matters while playing at the highest level of the game.
“Our ambition is to create a game where women and girls can thrive,” said Sue Day, the FA’s director of women’s football.
“To achieve that, it’s essential that players feel supported in environments that understand and respond to their female health needs.
“We’ve heard directly from grassroots players that they want better information and support around female health, but that they often don’t know where to find it.
“The launch of the Female Health Hub marks an important step in changing the landscape.
“We want every player to feel confident in her own skin and supported without judgment, so she can feel empowered by her body, rather than held back by it.”
The platform was launched following research conducted by the FA that highlighted the need for better education and support around female health in football.
According to the FA, 88 per cent of adult players surveyed said their menstrual cycle has an impact on their ability to train or play, but 86 per cent reported they had never received education about the menstrual cycle in relation to football performance and training.
The research also found 64 per cent of women experience issues related to sports bras or breast health while playing football, despite sports bras being considered one of the most important pieces of playing kit.
Players also expressed strong interest in learning more about injury prevention, at 87 per cent, nutrition, at 84 per cent, and mental health, at 77 per cent, in relation to female health.
The first phase of the Female Health Hub focuses on three of the most requested topics: menstrual health, breast health and injury resilience, with further content to follow, including nutrition and pelvic health guidance.
Pregnancy
Women’s health strategy a ‘missed opportunity,’ RCM says
Fertility
Genetic carrier screening before pregnancy: What to know

Article produced in association with London Pregnancy Clinic and Jeen Health
For the majority of couples planning a pregnancy, genetic testing is not something they think about until a problem arises.
Pre-conception genetic carrier screening challenges this approach by identifying risk before pregnancy begins.
As panel sizes have grown and at-home testing options have become widely available, carrier screening is transitioning from a niche clinical referral into a mainstream component of reproductive planning.
What Carrier Screening Tests For
Being a carrier of a genetic condition means carrying one copy of a variant in a gene associated with that condition, without being affected by it.
In most cases, carriers are entirely unaware of their status.
The clinical significance of carrier status emerges when both members of a couple carry a variant in the same gene: in this scenario, each pregnancy carries a one in four chance of resulting in a child who inherits two copies of the variant and is affected by the condition.
The conditions most frequently included in expanded carrier screening panels include cystic fibrosis, spinal muscular atrophy (SMA), fragile X syndrome, sickle cell disease, and a range of metabolic and enzyme deficiency disorders.
The Beacon 787 carrier test, offered by Jeen Health, screens for 787 conditions from a single sample, making it one of the most comprehensive panels currently available to UK families.
Who Is Most Likely to Benefit
Any couple planning a pregnancy can consider carrier screening. It is particularly relevant for:
- Couples with a family history of a known inherited condition
- Those from populations with higher carrier frequencies for specific conditions, including Ashkenazi Jewish, South Asian and African communities
- Couples pursuing fertility treatment, where genetic information informs treatment planning
- Those who wish to have the most complete picture of their reproductive health before conception
Importantly, being a carrier of a condition does not mean a child will be affected. It means there is a defined statistical risk that can be quantified, discussed and planned for with appropriate clinical support.
How the Test Is Performed
Carrier screening is typically carried out on a blood or saliva sample.
For at-home options such as the testing offered by Jeen Health, a cheek swab collection kit is dispatched to the patient, the sample is returned by post, and results are delivered digitally within a defined turnaround period.
In-clinic carrier testing may use a blood draw and provides the advantage of immediate access to a clinical consultation at the point of result delivery.
London Pregnancy Clinic offers genetics counselling through its partnership with Jeen Health, allowing couples to receive and contextualise carrier test results with expert support.
Genetic counselling before and after testing is recommended by Genomics England as a standard component of any genomic testing pathway.
What Happens If Both Partners Are Carriers
If both partners are identified as carriers for the same autosomal recessive condition, they are typically offered further counselling to discuss their options.
These may include proceeding naturally with an awareness of the risk, using prenatal diagnosis (CVS or amniocentesis) during pregnancy to test the fetus, or pursuing preimplantation genetic testing (PGT) in the context of IVF, which allows unaffected embryos to be selected before transfer.
The purpose of identifying carrier status before pregnancy is to give couples time to consider these options without the added pressure of an ongoing pregnancy.
Knowledge of carrier status does not remove reproductive choices; it expands the information available when making them.
The Role of Pre-Conception Services
Carrier screening sits within a broader category of pre-conception care that includes fertility assessments, general health optimisation and, where relevant, management of existing conditions before pregnancy begins.
London Pregnancy Clinic offers pre-conception services encompassing fertility investigations, genetics counselling and carrier testing as part of an integrated 0th trimester approach, allowing couples to address genetic and clinical risk factors before their pregnancy starts rather than after.
Disclaimer: This article is produced for informational purposes only and does not constitute medical advice, diagnosis or treatment.
Clinical guidance referenced reflects published NHS, NICE and RCOG standards as at March 2026. Individual circumstances vary; readers are advised to consult a qualified healthcare professional before acting on any information in this article.
This piece was produced in association with London Pregnancy Clinic and Jeen Health, which provided background clinical information for editorial purposes.
Hyperlinks to external sources are included for reference only and do not represent an endorsement of any product, service or organisation.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Menopause4 weeks agoCalifornia plans US$3.4m menopause care overhaul
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause3 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News2 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up














